ID   NCF3
AC   CVCL_IN83
DR   Wikidata; Q54907700
RX   PubMed=2470608;
RX   PubMed=15463957;
CC   Doubling time: ~48 hours (PubMed=2470608).
CC   Karyotypic information: Near tetraploid karyotype (PubMed=2470608).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Nose, nasal cavity, epithelium; Note=From a nasal polyp; UBERON=UBERON_0005384.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
CH   CVCL_IN84 ! NCF3A
//
RX   PubMed=15463957; DOI=10.1016/j.jcf.2004.05.040;
RA   Gruenert, Dieter C.
RA   Willems, Marjolaine
RA   Cassiman, Jean-Jacques
RA   Frizzell, Raymond A.
RT   "Established cell lines used in cystic fibrosis research.";
RL   J. Cyst. Fibros. 3:191-196(2004).
//
RX   PubMed=2470608; DOI=10.1016/0014-4827(89)90259-0;
RA   Scholte, Bob J.
RA   Kansen, Maarten
RA   Hoogeveen, Andre T.
RA   Willemse, Rob
RA   Rhim, Johng Sik
RA   van der Kamp, Arthur W.M.
RA   Bijman, Jan
RT   "Immortalization of nasal polyp epithelial cells from cystic fibrosis
RT   patients.";
RL   Exp. Cell Res. 182:559-571(1989).
//